Growth Metrics

MediXall (MDXL) FCF Margin (2021 - 2024)

MediXall's FCF Margin history spans 4 years, with the latest figure at 1023.58% for Q3 2024.

  • For Q3 2024, FCF Margin fell 62087.0% year-over-year to 1023.58%; the TTM value through Sep 2024 reached 395.05%, up 29653.0%, while the annual FY2023 figure was 397.37%, 561340.0% up from the prior year.
  • FCF Margin reached 1023.58% in Q3 2024 per MDXL's latest filing, down from 556.86% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 213.18% in Q4 2023 to a low of 39626.41% in Q1 2021.
  • Average FCF Margin over 4 years is 7476.15%, with a median of 1023.58% recorded in 2024.
  • The largest YoY upside for FCF Margin was 2536262bps in 2022 against a maximum downside of -814823bps in 2022.
  • A 4-year view of FCF Margin shows it stood at 13974.39% in 2021, then surged by 79bps to 2955.5% in 2022, then soared by 93bps to 213.18% in 2023, then plummeted by -380bps to 1023.58% in 2024.
  • Per Business Quant, the three most recent readings for MDXL's FCF Margin are 1023.58% (Q3 2024), 556.86% (Q2 2024), and 261.42% (Q1 2024).